Getting Smart about Diabetes

A representative sample patient population that accurately reflects the overall population is vital to establish the safety and efficacy of a drug.

Harnessing these tools for successful integration and streamlining of processes.

The current clinical development model is shifting toward a generative AI-augmented proactive approach supported by real-world data for real time evidence.

Following a webinar on the use of a medical device in a migraine clinical trial, Mowlem caught up with ACT to discuss her biggest takeaways and what she is currently seeing in the digital trials space.

Amplifying the size and diversity of participant pools in clinical trials enhances statistical power and increases the generalizability of study findings.

New and renewed approaches to improve chances of success in developing non-addictive drugs for chronic pain.